Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Malinverni C, Bernardelli A, Glimelius I, Mirandola M, Ekstrom Smedby KE, Tisi MC, Giné E, Albertsson-Lindblad A, Marin-Niebla AM, Di Rocco A, Moita F, Sciarra R, Bašić-Kinda S, Hess GR, Ohler A, Eskelund CW, Re A, Ferrarini I, Kolstad A, Räty RK, Quaglia FM, Eyre TA, Scapinello G, Stefani PM, Morello L, Nassi L, Hohaus S, Ragaini S, Zilioli VR, Bruna R, Cocito F, Arcari A, Jerkeman M, Visco C.
Malinverni C, et al.
Blood. 2024 May 16:blood.2023023525. doi: 10.1182/blood.2023023525. Online ahead of print.
Blood. 2024.
PMID: 38754055